Cronos Group Inc. (CRON)
- Previous Close
2.0000 - Open
1.9800 - Bid 1.9600 x 3100
- Ask 2.0000 x 1700
- Day's Range
1.9800 - 2.0400 - 52 Week Range
1.6000 - 3.1400 - Volume
1,483,263 - Avg. Volume
1,617,477 - Market Cap (intraday)
763.831M - Beta (5Y Monthly) 1.52
- PE Ratio (TTM)
14.14 - EPS (TTM)
0.1400 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.91
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
thecronosgroup.com459
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CRON
View More
Performance Overview: CRON
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRON
View MoreValuation Measures
Market Cap
763.83M
Enterprise Value
-72.17M
Trailing P/E
14.14
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.09
Price/Book (mrq)
0.72
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
34.93%
Return on Assets (ttm)
-2.94%
Return on Equity (ttm)
3.63%
Revenue (ttm)
117.61M
Net Income Avi to Common (ttm)
41.08M
Diluted EPS (ttm)
0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
858.8M
Total Debt/Equity (mrq)
0.18%
Levered Free Cash Flow (ttm)
-26.29M
Research Analysis: CRON
View MoreResearch Reports: CRON
View MoreCronos Group: Dropping Coverage
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Earnings: Shares Rally on Improved Results but We Don't Think the Stock Offers Much Upside
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCannabis Sector Fares Terribly in 2024 US Elections, but Market Overreacts to Long-Term Impact
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Remains Far From Critical Mass to Achieve Profitability; Cash Hoard Is Most of Its Value
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice Target